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Abstract 
A central quest in gene therapy and vaccination is to achieve effective and long-lasting 
gene expression at minimal dosage. Adenovirus vectors are widely used therapeutics 
and safely deliver genes into many cell types. Adenoviruses evolved to use elaborate 
trafficking and particle deconstruction processes, and efficient gene expression and 
progeny formation. Here, we discuss recent insights into how human adenoviruses 
deliver their double-stranded DNA genome into cell nuclei, and effect lytic cell killing, 
non-lytic persistent infection or vector gene expression. The mechanisms underlying 
adenovirus entry, uncoating, nuclear transport and gene expression provide a blueprint 
for the emerging field of synthetic virology, where artificial virus-like particles are 
evolved to deliver therapeutic payload into human cells without viral proteins and 
genomes.  
 




Virus entry; uncoating; receptor; endocytosis; membrane penetration; cytoplasmic 
transport; nuclear import; E3 ubiquitin ligase; E1A gene expression; virus-like particle; 
laboratory virus evolution; nucleic acid packaging; anti-virus immunity;  
 
 
Highlights for discovery 
-Stability and built-in weaknesses are emergent properties of adenovirus particles and 
key for gene delivery 
-Entry is a gain of function process where the virion uncoats in a stepwise manner and 
adapts to the subcellular environment 
-The ubiquitin ligase Mib1 triggers the release of the DNA genome from the capsid at 
the nuclear pore complex  
-Adenovirus gene expression exhibits cell-to-cell and genome-to-genome variability 






Human cervical epithelial HeLa cells grown on sapphire coverslips were infected with 
HAdV-C5 at a high multiplicity in presence of leptomycin B for 5 h, high pressure frozen 
using liquid nitrogen at 2100 bar, and freeze-substituted. Thin sections of 70 nm 
thickness were imaged using transmission electron microscopy at the Center for 
Microscopy and Image Analysis (ZMB) of the University of Zurich. (V) Virus particle, 





Viruses are highly prevalent and diverse, yet specialized and typically well adapted to 
their hosts. They propagate and spread within and between organisms, package a 
nucleic acid genome into a protein capsid and unpack the same genome upon entry 
into a naive host cell. Viruses evolved intricate assembly and disassembly processes. 
For some viruses, such as bacteriophages, these processes are understood at the level 
of molecules, biophysical features and nucleotide precision genetics [for overviews, 
see 1,2,3]. Challenges remain, however, to better understand the complex processes 
occurring in virus infection of eucaryotic cells.  
The Studies of human adenovirus (HAdV) interactions with cells have a long track 
record, with seminal contributions from molecular and cell biology, virology, 
immunology, and more recently gene therapy and vaccinology [for recent reviews, see 
4,5-8]. HAdVs are grouped into seven species (A-G) and comprise more than 100 
types, as indicated by serology and genome sequencing [reviewed in 9,10]. Their 
number currently exceeds that of known animal adenoviruses. HAdVs infect the 
respiratory and the gastrointestinal organs, the kidneys and the eyes, and are life-
threatening in T cell suppressed individuals [reviewed in 11]. A typical HAdV genome 
has about 36 kbp, and encodes 30-40 distinct proteins in early (E) or late (L) genes 
[12], not counting potential proteins from more than 11’000 alternatively spliced mRNAs 
[13]. The AdV genome replicates in the nucleus and leads to the formation of discrete 
zones of virion assembly in this organelle.  
The assembly of AdV particles 
Adenoviruses have high structural similarity to bacteriophages [reviewed in 3]. Their 
assembly is an elaborate process depending on the large abundance of capsomers, 
genomes, and assembly factors. AdV capsomers are put together in specialized 
domains of the nucleus, so called replication zones. Although AdVs encode a putative 
ATP-binding protein IVa2 implicated in viral DNA packaging, and give rise to empty 
capsids lacking viral DNA [14-16], they do not use empty capsids as an intermediate in 
the formation of infectious virions, unlike herpes viruses, which also replicate a linear 
double-stranded DNA genome in the nucleus. Empty HAdV capsids are stable, and are 
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most likely a defective assembly product, as they do not mature into infectious particles 
[17,18]. HAdV capsids package viral DNA both in presence and absence of the major 
viral DNA condensing protein VII [19,20]. Protein VII firmly associates with newly 
synthesized viral DNA in the nucleus, is packaged into progeny virions, and remains 
associated with the viral genome until delivery into the nucleus in a new round of 
infection [21,22]. It is unlikely that a DNA packaging machinery pumps two very different 
substrates, viral DNA with or without protein VII through a hypothetical portal complex 
into preformed empty capsids. It is more likely that packaging of the HAdV genome 
occurs by coordinated interactions of different viral proteins, including IIIa, L1 52/55K, 
L4 33K, L4 22K and IVa2.  
The organisation of the adenoviral DNA in the capsid has remained elusive, although 
several mature capsids were resolved at near atomic details, including the respiratory 
C5, the ocular D26 and the enteric F41 [23-26]. Their icosahedral structures reveal a 
tight interconnection of the major capsid protein hexon and various minor proteins 
[25,27]. The capsid and protrusions from the vertices give rise to emergent properties 
of the virion, including stability, cell receptor binding but also physico-chemical 
weaknesses [reviewed in 28,29]. For example, the penton base proteins at the vertices 
readily detach upon application of mechanical force to single isolated virions by atomic 
force microscopy AFM, or by receptor engagement on the plasma membrane of host 
cells [30-32]. The detachment of the fibers from the incoming virion [33], which binds 
with high affinity to its receptor [34], is important to release the particle to the cytosol, 
and facilitate cytoplasmic trafficking to the nucleus. The release of the penton base is 
thought to open up the particles to release the membrane lytic protein VI [for review, 
see 35].  
Adenovirus attachment to cells 
The fiber knob is a major binding determinant for most HAdVs on cells and tissue. Its 
tertiary structure is conserved across the seven different HAdV species, but variable in 
amino acid composition, particularly in the hypervariable loops. In most cases, the knob 
attaches to the coxsackievirus AdV receptor (CAR), CD46, desmoglein (DSG) 2, or 
sialic acid [reviewed in 36]. These receptors vary in abundance on target cells, as well 
as affinity for the particular fiber knobs. Since the fiber knobs occur in as many as 12 
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homotrimers per virion, they overcome low affinity binding to receptors by avidity 
engagement, as shown initially for the HAdV-B3 fiber knob binding to the ubiquitous 
membrane cofactor CD46 [37]. Fiber knobs may also bind to not just one receptor, but 
multiple ones, for example as suggested for the vaccine vector HAdV-D26, which binds 
CAR and sialic acid with low affinity [38,39], and engages αVβ3 integrins through penton 
base [40].  
Increasing evidence demonstrates that besides fiber knob and penton base, hexon is 
an important mediator of HAdV binding to particular cell types. For example, the hexon 
hypervariable region HVR1 attaches HAdV-B35, HAdV-D26 and HAdV-C5 to the 
scavenger receptor SR-A6 (MARCO) of alveolar-like macrophages, leading to 
macrophage transduction and cytokine production, as shown in knock-out alveolar-like 
macrophages and mouse models [41,42]. The D species comprises the largest number 
of HAdV types among all the seven species. Some D types, such as the vaccine vector 
HAdV-D26 have either low or high seroprevalence depending on the region of the 
globe, whereas others, such as HAdV-C5 are endemic in many countries [reviewed in 
7,43,44]. Vectors derived from HAdV-D26 but also HAdV-C5 are used as vaccines 
against COVID-19 [45], and HAdV-B35 based vectors are employed in hematopoietic 
stem cell transductions [46]. Hexon of HAdV-D56 particles binds to CD46, and a large 
excess of soluble CD46 inhibited the infection of epithelial cancer cells with HAdV-D26 
[47]. These data suggest that besides CAR and sialic acid, SR-A6 and CD46 may be 
involved in infections with species D HAdVs.  
Endocytosis, membrane penetration and cytoplasmic 
transport 
Infection and transduction require the uncoating and delivery of AdV genomes into the 
nucleus. The AdV entry and uncoating program is best described for species C HAdV 
types 2 and 5, and in principle applies to viruses of other species (Fig. 1). Mechanical 
forces acting on the HAdV-C particles expose the internal membrane lytic protein VI 
[reviewed in 29,35,48,49]. This is a key step and occurs when the virion is in contact 
with the appropriate receptors, such as coxsackievirus adenovirus receptor (CAR) and 
av integrins. Within the virion, the exposure and the release of protein VI is controlled 
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by a tunable mechanism, where the DNA-condensing protein VII competes with VI for 
binding to hexon, and poises the particle for exposing protein VI [50]. In absence of VII, 
VI cannot be exposed and virions fail to penetrate to the cytosol. Following dynamin-
mediated endocytosis, the exposed protein VI preferentially binds to ceramide lipid-rich 
membrane domains, and ruptures the limiting endosomal membrane. The partly 
dismantled capsid then uses dynein- and kinesin-mediated transport on microtubules 
to the nucleus, binds and uncoats at the nuclear pore complex (NPC), and imports a 
double-stranded linear DNA genome in complex with viral proteins into the nucleus 
[reviewed in 29]. Likewise, the ocular HAdV-D37 enters human corneal epithelial cells 
by a clathrin-mediated pathway independent of low pH, but unlike HAdV-C5 involves 
caveolae-signalling, lysosome-associated membrane protein 1 and the kinase PAK1, 
the latter akin to HAdV-B3, a hallmark of late-penetration [51,52]. Unlike the early 
penetrator HAdV-C5, the entry of HAdV-D37 into keratinocytes was enhanced by 
siRNA-mediated knock-down of dynamin-2, and inhibited by overexpression of 
dynamin-2, possibly involving alterations of microtubule dynamics [53]. The latter could 
relate to virion trafficking from the microtubules to the NPC, which requires a nuclear 
factor for virion detachment from microtubules proximal to the nucleus [54].  
Ubiquitination controlled AdV DNA uncoating at the NPC 
HAdV particles dock to the cytosolic side of the NPC, disassemble and deliver their 
genome through the NPC into the nucleus [reviewed in 55]. A genome-wide RNA 
interference screen with HAdV-C2-∆E3B-CMV-GFP revealed the RING-type E3 
ubiquitin ligase Mind bomb 1 (Mib1) as a proviral host factor for HAdV infections [56]. 
Mib1 is involved in embryogenesis and anti-viral RNA innate immunity. Its depletion 
strongly blocked HAdV-C2/5, A31, B3 and D8 infections, arrested incoming particles 
and their genomes at NPCs and inhibited viral DNA nuclear import. Induced expression 
of full-length but not ligase-defective Mib1 in knockout cells triggered vDNA uncoating 
from NPC-tethered virions, nuclear import and viral infection. These results were 
phenocopied by a recent gene-trap screen using a replication-defective HAdV-C5 
vector in haploid cells [57]. In both studies (Bauer et al. and Sarbanes et al.), HAdV 
infection required the ubiquitination activity of Mib1, suggesting that Mib1 signals to 
dissociate or degrade cellular or viral factor(s), which block uncoating. One class of 
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cellular factors blocking the attachment of HAdV-C2 with NPCs in vitro are 
ribonucleoprotein (RNP) particles [58]. Interestingly, a proteomic screen of HAdV 
infected cells identified RNP proteins to be ubiquitinated in proximity to Mib1 [57]. The 
results suggest a scenario where deubiquitinated RNPs shield the HAdV from 
uncoating, whereas ubiquitinated RNPs are permissive for HAdV uncoating.  
In addition to potential host factors, Mib1 targets the virion protein V [59]. Protein V 
constitutes nearly 30% of the protein mass of the viral DNA-core, while 70% is from 
protein VII, protein X and the terminal protein. Protein V links the core with the capsid 
wall via protein VI. It dissociates in two steps from the incoming particle. In the early 
phase of entry about 65% of V are released, and during DNA uncoating at the NPC the 
remaining is released [21]. HAdV-C5 particles lacking protein V poorly infect normal 
cells, unlike wild-type virus, but readily infect Mib1-knockout cells [59]. In normal cells, 
the V-minus HAdV-C5 releases the genome before reaching the NPC, which triggers 
the production of chemokines and interferon in response to the DNA sensor cGAS. 
Likewise, HAdV-C5 particles containing non-ubiquitinable protein V (all lysine residues 
mutated to arginine) showed reduced nuclear import and enhanced levels of cytosolic 
viral DNA. The data show that protein V serves as a linchpin in the virion suppressing 
the exposure of pathogen-associated molecular patterns. Mib1 triggers the quantitative 
release of protein V from the virion, and thereby primes the virion for kinesin-mediated 
rupture, followed by nuclear import of the viral DNA and infection [60].  
In summary, the HAdV entry and uncoating processes have features best described as 
a sequence of discrete steps, but without evidence for an empty capsid intermediate at 
the NPC. This is distinct from herpes viruses, which open up a single vertex upon arrival 
at the NPC, release the double stranded DNA and leave an empty capsid in the 
cytoplasm [reviewed in 55].   
Early gene expression from incoming viral DNA  
A central quest in viral gene therapy and vaccination is the effective and long lasting 
expression of exogenous genes of interest at minimal vector dosage. This is difficult to 
achieve because the vector of choice may transduce insufficiently due to a paucity of 
cell receptor expression [61,62], limited uncoating of its genome, aberrant intracellular 
 9 
trafficking, or innate and adaptive immunity precluding vector gene expression. 
Genomes of DNA viruses, such as AdVs, are transcribed by host RNA polymerases 
(Pol), and suppressed by innate immune responses, conditions that lead to virus 
persistence albeit without integration into the host genome [for review, see 11].  
For example, the immediate early protein E1A drives AdV infection by controlling the 
subviral and numerous cellular promoters, except those controlling the expression of 
virus-associated (VA) RNAs, which require RNA Pol III [63]. Together with the anti-
apoptotic E1B-19K and the multifunctional 55K proteins, E1A controls pathways for cell 
proliferation, differentiation and homeostasis. The latter involves the endoplasmic 
reticulum unfolded protein response (UPRER), where it engages the transmembrane 
sensor Ire1a in a transcriptional feed-forward loop [reviewed in 64]. Ire1a has a kinase 
and nuclease activity. The nuclease is triggered by the viral E3-19K glycoprotein in the 
ER lumen, and catalyzes the splicing of the mRNA encoding X-box binding protein 
(XBP) 1, yielding active transcription factor XBP1s, which binds to the E1A promoter 
and enhances E1A transcription [65]. A loop of five components (E1A, E3-19K, Ire1a, 
XBP1s and the E1A-promoter) stimulates lytic infection outcome, and viral persistence 
in presence of the anti-viral cytokine interferon [65,66]. The maintenance of E1A 
expression is important for long lasting viral gene expression, since E1A suppresses 
the expression of interferon-stimulated genes by inhibiting, for example, the E3 
ubiquitin ligase hBre1 [67,68].  
But the picture is more complex, as indicated by the heterogeneity of cell responses to 
infection. Recent single-cell, single-genome studies with HAdV-C5 revealed high cell-
to-cell variability of E1A expression, ranging from nuclei with as many as 25 viral 
genomes and no E1A expression to others with as few as one or two genomes and 
more than 30 E1A transcripts [69]. This heterogeneity is observed at early time points 
post infection, but later almost all infected A549 cells become loaded with E1A mRNAs, 
before these transcripts disappear at the later stages of infection. Despite this 
heterogeneity, there is a clear correlation between the number of viral genomes and 
E1A transcripts, and this correlation is increased in G1 cells, suggesting that the cell 
cycle state contributes to the heterogeneity of infection, albeit mildly.  
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Viral chromatin remodelling is an important process controlling AdV gene expression. 
The incoming viral genome is condensed with the DNA binding protein VII, which 
shields repulsive DNA-DNA interactions, and reduces the internal pressure in the virion 
[20]. Protein VII also condenses the viral DNA in the penton-low cytoplasmic capsids 
trafficking in endosomes and the cytosol [70]. Upon disruption of the capsid at the NPC, 
protein VII accompanies the viral DNA into the nucleus, but its role in the nucleus has 
been debated. Some evidence suggests that protein VII supports early viral 
transcription [71,72], while other data argue that its removal from the viral DNA is 
essential for transcription and replication [73,74]. Positional heterogeneity of protein VII 
on the viral DNA may account for some of the observed variability in E1A expression, 
and viral replication. Regardless, limiting dilution and live cell plaque formation 
experiments have recently shown that the outcome of AdV infection is three-fold: 
aberrant (without the spreading of progeny to neighboring cells), non-lytic (small 
symmetrical plaques) and lytic (large smeary plaques) [75]. Microscopy machine-
learning revealed a distinction between lytic and non-lytic infected cells, namely the 
intranuclear pressure increased in lytic infected cells compared to non-lytic cells [76]. 
Future investigations will continue to take advantage of predictive imaging from 
machine-learning and explore the infection variability, which has been a long-standing 
challenge to both biologists and virologists.  
Synthetic viruses 
One approach to address viral mechanisms is synthetic virology. This field may help to 
understand fundamental problems, for example along the famous note of Richard 
Feynman ‘What I cannot create I do not understand’. Synthetic virology engineers virus-
like particles, ideally to deliver cargo on demand to any cell of interest in the body. Such 
virus-like particles are not found in nature, and mimic features of viruses, including 
cubic, icosahedral, or helical assemblies, scaffolds, glues, and cores of nucleic acids 
and proteins [reviewed in 77]. Arguably, a foundation for synthetic virology was laid with 
the chemical synthesis of poliovirus [78], and extended for example by the reversible 
assembly of virus-like protein cages under the control of metal coordination at the 
protein interfaces [79]. More recently, laboratory evolution of bacterial enzymes, such 
as the Aquifex aerolicus lumazine synthase (AaLS) involved in riboflavin synthesis gave 
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rise to virus-like capsids that package RNA [80,81]. The synthetic evolution process 
has been expanded by complementary adaptations between cargo and container to 
T=4 particles, which selectively package RNA [82]. This was achieved by including the 
lambda N peptide at the amino terminus of AaLS and flanking the capsid-encoding 
RNA with a stem loop structure recognized by lambda N. So far, however, the capsids 
have remained unresponsive to uncoating cues and failed to release RNA or penetrate 
into the cytosol of target cells. In analogy to natural viruses, this suggests that further 
components are required to achieve proper cargo delivery to target cells. It will be 
essential to build in a tunable endosomal escape machinery, akin to the host factor 
controlled release of the membrane lytic protein VI of HAdV [83,84]. Intriguingly, the 
membrane lytic domain of protein VI genetically fused to the vault poly(ADP-ribose) 
polymerase interaction domain was active in mediating the co-delivery of a soluble 
ribotoxin or plasmid DNA into murine macrophages [85].  
The limited cargo carrier capacity of vaults, however, requires further development of 
adaptable systems. In particular, the cargo capacity of capsids may be enlarged by 
devising multi-subunit cages, keeping in mind, however, an upper size limit owing to 
energetic cost, as shown for viral capsids [86]. Furthermore, the release of the cargo, 
such as RNA, from the capsid to the cytosol has to be increased, perhaps by shortening 
the packaging signal on the RNA, and splitting it into different elements, akin to AdVs, 
which contain multiple short stretches of A repeat (AT-rich) sequence elements at the 
left end of the genome for directing the packaging process [reviewed in 87]. These 
considerations highlight the importance of using combinatorial evolutionary selection 
processes in virus-like particle biogenesis, and considering the blueprints provided by 
viruses, such as adenovirus.  
Conclusions 
Viral nanomachines evolved by natural selection. They cycle between assembly in 
infected and disassembly in uninfected cells. Adenoviruses are among the best studied 
of them, and have contributed to a detailed understanding of the viral nature and the 
functioning of cells and organisms. Currently, the state-of-the-art in virus research 
extends from population averaged structural analyses and infection studies towards 
structural, physical and biological analyses of single virions and single infected cells, 
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for example by atomic force microscopy, nanofluidics and single cell genomics [88-90]. 
Detailed studies of the assembly and the disassembly processes with single virion 
resolution will continue to provide insights into the natural mechanisms of viruses 
including adenoviruses, and inspire the evolution of synthetic viruses for precision 
delivery in human and animal therapies.  
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Fig. 1: Cost and effect of AdV entry into cells 
Adenovirus entry into cells delivers danger signals activating pattern recognition 
receptors, such as toll-like receptor 9 (TLR9) recognizing double-stranded endosomal 
DNA, galectin 3 and 8 targeting broken membranes to autophagy through the adaptor 
NDP52, and sensors detecting abnormal DNA, including interferon-inducible 
protein absent in melanoma 2 (AIM2), cyclic GMP-AMP synthase (cGas) and interferon 
gamma inducible protein 16 (IFI16). Together, these activated sensors trigger cell type 
specific innate and inflammatory immune responses, which typically negatively 
regulate viral gene expression and replication in the cell nucleus. For additional 







1. Koonin EV, Dolja VV, Krupovic M: Origins and evolution of viruses of eukaryotes: 
The ultimate modularity. Virology 2015, 479-480C:2-25. 
2. Mai-Prochnow A, Hui JG, Kjelleberg S, Rakonjac J, McDougald D, Rice SA: 'Big 
things in small packages: the genetics of filamentous phage and effects 
on fitness of their host'. FEMS Microbiol Rev 2015, 39:465-487. 
3. Oksanen HM, Abrescia NGA: Membrane-Containing Icosahedral Bacteriophage 
PRD1: The Dawn of Viral Lineages. Adv Exp Med Biol 2019, 1215:85-109. 
4. Nemerow G, Flint J: Lessons learned from adenovirus (1970-2019). FEBS Lett 
2019, 593:3395-3418. 
5. Allen RJ, Byrnes AP: Interaction of adenovirus with antibodies, complement, 
and coagulation factors. FEBS Lett 2019, 593:3449-3460. 
6. Gao J, Mese K, Bunz O, Ehrhardt A: State-of-the-art human adenovirus 
vectorology for therapeutic approaches. FEBS Lett 2019, 593:3609-3622. 
7. Barry MA, Rubin JD, Lu SC: Retargeting adenoviruses for therapeutic 
applications and vaccines. FEBS Lett 2020. 
8. Greber UF: Adenoviruses - Infection, pathogenesis and therapy. FEBS Lett 
2020, 594:1818-1827. 
9. Harrach B, Tarjan ZL, Benko M: Adenoviruses across the animal kingdom: a 
walk in the zoo. FEBS Lett 2019, 593:3660-3673. 
10. Bots STF, Hoeben RC: Non-Human Primate-Derived Adenoviruses for Future 
Use as Oncolytic Agents? Int J Mol Sci 2020, 21. 
11. Lion T: Adenovirus persistence, reactivation, and clinical management. FEBS 
Lett 2019, 593:3571-3582. 
12. Hoeben RC, Uil TG: Adenovirus DNA replication. Cold Spring Harb Perspect Biol 
2013, 5:a013003. 
13. Donovan-Banfield I, Turnell AS, Hiscox JA, Leppard KN, Matthews DA: Deep 
splicing plasticity of the human adenovirus type 5 transcriptome drives 
virus evolution. Commun Biol 2020, 3:124. 
14. Christensen JB, Byrd SA, Walker AK, Strahler JR, Andrews PC, Imperiale MJ: 
Presence of the adenovirus IVa2 protein at a single vertex of the mature 
virion. Journal of Virology 2008, 82:9086-9093. 
15. Zhang W, Low JA, Christensen JB, Imperiale MJ: Role for the adenovirus IVa2 
protein in packaging of viral DNA. J Virol 2001, 75:10446-10454. 
16. Ostapchuk P, Hearing P: Adenovirus IVa2 protein binds ATP. J Virol 2008, 
82:10290-10294. 
17. Khittoo G, Weber J: Genetic analysis of adenovirus type 2. VI. A temperature-
sensitive mutant defective for DNA encapsidation. Virology 1977, 81:126-
137. 
18. Ostapchuk P, Almond M, Hearing P: Characterization of Empty adenovirus 
particles assembled in the absence of a functional adenovirus IVa2 
protein. J Virol 2011, 85:5524-5531. 
19. Ostapchuk P, Suomalainen M, Zheng Y, Boucke K, Greber UF, Hearing P: The 
adenovirus major core protein VII is dispensable for virion assembly but 
is essential for lytic infection. PLoS Pathog 2017, 13:e1006455. 
20. Martin-Gonzalez N, Hernando-Perez M, Condezo GN, Perez-Illana M, Siber A, 
Reguera D, Ostapchuk P, Hearing P, San Martin C, de Pablo PJ: Adenovirus 
major core protein condenses DNA in clusters and bundles, modulating 
 15 
genome release and capsid internal pressure. Nucleic Acids Res 2019, 
47:9231-9242. 
21. Puntener D, Engelke MF, Ruzsics Z, Strunze S, Wilhelm C, Greber UF: Stepwise 
loss of fluorescent core protein V from human adenovirus during entry 
into cells. J Virol 2011, 85:481-496. 
22. Mangel WF, San Martin C: Structure, Function and Dynamics in Adenovirus 
Maturation. Viruses 2014, 6:4536-4570. 
23. Liu H, Jin L, Koh SB, Atanasov I, Schein S, Wu L, Zhou ZH: Atomic structure of 
human adenovirus by cryo-EM reveals interactions among protein 
networks. Science 2010, 329:1038-1043. 
24. Reddy VS, Natchiar SK, Stewart PL, Nemerow GR: Crystal structure of human 
adenovirus at 3.5 A resolution. Science 2010, 329:1071-1075. 
25. Yu X, Veesler D, Campbell MG, Barry ME, Asturias FJ, Barry MA, Reddy VS: Cryo-
EM structure of human adenovirus D26 reveals the conservation of 
structural organization among human adenoviruses. Sci Adv 2017, 
3:e1602670. 
26. Rafie K, Lenman A, Fuchs J, Rajan A, Arnberg N, Carlson LA: The structure of 
enteric human adenovirus 41-A leading cause of diarrhea in children. Sci 
Adv 2021, 7. 
27. San Martin C: Latest insights on adenovirus structure and assembly. Viruses 
2012, 4:847-877. 
28. Parent KN, Schrad JR, Cingolani G: Breaking Symmetry in Viral Icosahedral 
Capsids as Seen through the Lenses of X-ray Crystallography and Cryo-
Electron Microscopy. Viruses 2018, 10. 
29. Greber UF, Flatt JW: Adenovirus Entry: From Infection to Immunity. Annu Rev 
Virol 2019, 6:177-197. 
30. Burckhardt CJ, Suomalainen M, Schoenenberger P, Boucke K, Hemmi S, Greber 
UF: Drifting motions of the adenovirus receptor CAR and immobile 
integrins initiate virus uncoating and membrane lytic protein exposure. 
Cell Host Microbe 2011, 10:105-117. 
31. Ortega-Esteban A, Bodensiek K, San Martin C, Suomalainen M, Greber UF, de 
Pablo PJ, Schaap IA: Fluorescence Tracking of Genome Release during 
Mechanical Unpacking of Single Viruses. ACS Nano 2015, 9:10571-10579. 
32. Denning D, Bennett S, Mullen T, Moyer C, Vorselen D, Wuite GJL, Nemerow G, 
Roos WH: Maturation of adenovirus primes the protein nano-shell for 
successful endosomal escape. Nanoscale 2019. 
* Mechanical fatigue experiments show that the mature HAdV capsid first loses the 
pentons, followed by either long-term capsid stability or abrupt and complete 
disassembly, suggesting that penton destabilization primes the capsid for 
controlled disassembly. 
 
33. Greber UF, Willetts M, Webster P, Helenius A: Stepwise dismantling of 
adenovirus 2 during entry into cells. Cell 1993, 75:477-486. 
34. Kirby I, Davison E, Beavil AJ, Soh CP, Wickham TJ, Roelvink PW, Kovesdi I, Sutton 
BJ, Santis G: Mutations in the DG loop of adenovirus type 5 fiber knob 
protein abolish high-affinity binding to its cellular receptor CAR. J Virol 
1999, 73:9508-9514. 
 16 
35. Luisoni S, Greber UF: Biology of Adenovirus Cell Entry – Receptors, Pathways, 
Mechanisms. In Adenoviral Vectors for Gene Therapy, edn 2nd. Edited by 
Curiel D: Academic Press, Elsevier; 2016:27-58.  
36. Stasiak AC, Stehle T: Human adenovirus binding to host cell receptors: a 
structural view. Med Microbiol Immunol 2020, 209:325-333. 
37. Trinh HV, Lesage G, Chennamparampil V, Vollenweider B, Burckhardt CJ, Schauer 
S, Havenga M, Greber UF, Hemmi S: Avidity binding of human adenovirus 
serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. 
Journal of Virology 2012, 86:1623-1637. 
38. Baker AT, Mundy RM, Davies JA, Rizkallah PJ, Parker AL: Human adenovirus 
type 26 uses sialic acid-bearing glycans as a primary cell entry receptor. 
Sci Adv 2019, 5:eaax3567. 
* The study provides structural and modelling data showing that the knob domain of 
the HAdV-D26/48 particles binds with low affinity to CAR, but not CD46 or 
DGS2.  
 
39. Baker AT, Greenshields-Watson A, Coughlan L, Davies JA, Uusi-Kerttula H, Cole 
DK, Rizkallah PJ, Parker AL: Diversity within the adenovirus fiber knob 
hypervariable loops influences primary receptor interactions. Nat Commun 
2019, 10:741. 
40. Nestic D, Uil TG, Ma J, Roy S, Vellinga J, Baker AH, Custers J, Majhen D: 
alphavbeta3 Integrin Is Required for Efficient Infection of Epithelial Cells 
with Human Adenovirus Type 26. J Virol 2019, 93. 
41. Maler MD, Nielsen PJ, Stichling N, Cohen I, Ruzsics Z, Wood C, Engelhard P, 
Suomalainen M, Gyory I, Huber M, et al.: Key Role of the Scavenger Receptor 
MARCO in Mediating Adenovirus Infection and Subsequent Innate 
Responses of Macrophages. MBio 2017, 8. 
42. Stichling N, Suomalainen M, Flatt JW, Schmid M, Pacesa M, Hemmi S, 
Jungraithmayr W, Maler MD, Freudenberg MA, Pluckthun A, et al.: Lung 
macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-
specific virus entry receptor. PLoS Pathog 2018, 14:e1006914. 
* The murine scavenger receptor SR-A6 (MARCO) is an receptor for HAdV-C5, D26 
and B35 binding to the hypervariable region 1 of hexon and leading to 
transduction of murine macrophages. Together with earlier data from Maler et 
al. mBio 2017 (DOI: 10.1128/mBio.00670-17) the results show that SR-A6 
stimulates the innate immune response in macrophages against HAdV.  
 
43. Mohamed Ismail A, Zhou X, Dyer DW, Seto D, Rajaiya J, Chodosh J: Genomic 
foundations of evolution and ocular pathogenesis in human adenovirus 
species D. FEBS Lett 2019, 593:3583-3608. 
44. Mennechet FJD, Paris O, Ouoba AR, Salazar Arenas S, Sirima SB, Takoudjou 
Dzomo GR, Diarra A, Traore IT, Kania D, Eichholz K, et al.: A review of 65 
years of human adenovirus seroprevalence. Expert Rev Vaccines 2019, 
18:597-613. 
45. Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, 
Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et 
al.: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous 
prime-boost COVID-19 vaccine: an interim analysis of a randomised 
controlled phase 3 trial in Russia. Lancet 2021. 
 17 
46. Li C, Lieber A: Adenovirus vectors in hematopoietic stem cell genome editing. 
FEBS Lett 2019, 593:3623-3648. 
47. Persson BD, John L, Rafie K, Strebl M, Frangsmyr L, Ballmann MZ, Mindler K, 
Havenga M, Lemckert A, Stehle T, et al.: Human species D adenovirus hexon 
capsid protein mediates cell entry through a direct interaction with CD46. 
Proc Natl Acad Sci U S A 2021, 118. 
* The study uses cryo-EM as well as receptor lacking cells to suggest that the species 
D HAdV-D56 uses the hexon protein to bind to CD46, and transduce cells.  
 
48. Wolfrum N, Greber UF: Adenovirus signalling in entry. Cell Microbiol 2013, 
15:53-62. 
49. Warren JC, Cassimeris L: The contributions of microtubule stability and 
dynamic instability to adenovirus nuclear localization efficiency. Cell Motil 
Cytoskeleton 2007, 64:675-689. 
50. Hernando-Perez M, Martin-Gonzalez N, Perez-Illana M, Suomalainen M, Condezo 
GN, Ostapchuk P, Gallardo J, Menendez M, Greber UF, Hearing P, et al.: 
Dynamic competition for hexon binding between core protein VII and lytic 
protein VI promotes adenovirus maturation and entry. Proc Natl Acad Sci U 
S A 2020. 
** Cryo-EM, virus mutagenesis and cell biological experiments give rise to a model 
coupling virion morphogenesis and entry, where the internal proteins VI and VII 
of the virion compete for binding to the major hexon cavity, and thereby facilitate 
their proteolytic maturation in assembly and release from the particle for 
membrane penetration during entry.  
 
51. Lee JS, Mukherjee S, Lee JY, Saha A, Chodosh J, Painter DF, Rajaiya J: Entry of 
Epidemic Keratoconjunctivitis-Associated Human Adenovirus Type 37 in 
Human Corneal Epithelial Cells. Invest Ophthalmol Vis Sci 2020, 61:50. 
52. Amstutz B, Gastaldelli M, Kalin S, Imelli N, Boucke K, Wandeler E, Mercer J, Hemmi 
S, Greber UF: Subversion of CtBP1-controlled macropinocytosis by human 
adenovirus serotype 3. EMBO J 2008, 27:956-969. 
53. Lee JS, Ismail AM, Lee JY, Zhou X, Materne EC, Chodosh J, Rajaiya J: Impact of 
dynamin 2 on adenovirus nuclear entry. Virology 2019, 529:43-56. 
* The study used RNAi to show that dynamin 2 inhibited species D HAdV-D37 entry 
and replication by interference with a step in the cytoplasm upstream of 
association with the nuclear membrane, thereby leading to enhanced innate 
immune response in the infected cell.  
 
54. Wang IH, Burckhardt CJ, Yakimovich A, Morf MK, Greber UF: The nuclear export 
factor CRM1 controls juxta-nuclear microtubule-dependent virus 
transport. J Cell Sci 2017, 130:2185-2195. 
55. Flatt JW, Greber UF: Viral mechanisms for docking and delivering at nuclear 
pore complexes. Semin Cell Dev Biol 2017, 68:59-71. 
56. Bauer M, Flatt JW, Seiler D, Cardel B, Emmenlauer M, Boucke K, Suomalainen M, 
Hemmi S, Greber UF: The E3 Ubiquitin Ligase Mind Bomb 1 Controls 
Adenovirus Genome Release at the Nuclear Pore Complex. Cell Rep 2019, 
29:3785-3795 e3788. 
** The first study to show that an E3 ubiquitin ligase, in this case Mind bomb 1 (Mib1) 
triggers the onset of virion uncoating at the nuclear pore complex, crucial for 
 18 
both, the delivery and the misdelivery of incoming viral DNA genome into the 
nucleus and cytosplasm, respectively.  
 
57. Sarbanes SL, Blomen VA, Lam E, Heissel S, Luna JM, Brummelkamp TR, Falck-
Pedersen E, Hoffmann HH, Rice CM: E3 ubiquitin ligase Mindbomb 1 
facilitates nuclear delivery of adenovirus genomes. Proc Natl Acad Sci U S 
A 2021, 118. 
** The second study to show that the catalytic activity of the E3 ubiquitin ligase Mib1 is 
required for HAdV DNA import into the nucleus.  
 
58. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF: Import of 
adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 
and histone H1. Nat Cell Biol 2001, 3:1092-1100. 
59. Bauer M, Gomez-Gonzalez A, Suomalainen M, Hemmi S, Greber UF: The E3 
ubiquitin ligase Mind bomb 1 enhances nuclear import of viral DNA by 
inactivating a virion linchpin protein that suppresses exposure of virion 
pathogen-associated molecular patterns. bioRxiv 2020. 
* The study uses genetically edited virions and single cell / single virion analyses to 
identify a linchpin function for the AdV capsid protein V, which confers virion 
stability as well as protection from cGAS anti-viral signalling in the cytosol, and 
is dissociated from the incoming particles upon ubiquitination in a Mib1 
dependent manner.  
 
60. Strunze S, Engelke MF, Wang IH, Puntener D, Boucke K, Schleich S, Way M, 
Schoenenberger P, Burckhardt CJ, Greber UF: Kinesin-1-mediated capsid 
disassembly and disruption of the nuclear pore complex promote virus 
infection. Cell Host Microbe 2011, 10:210-223. 
61. Walters RW, Grunst T, Bergelson JM, Finberg RW, Welsh MJ, Zabner J: 
Basolateral localization of fiber receptors limits adenovirus infection from 
the apical surface of airway epithelia. J Biol Chem 1999, 274:10219-10226. 
62. Coyne CB, Bergelson JM: CAR: a virus receptor within the tight junction. Adv 
Drug Deliv Rev 2005, 57:869-882. 
63. Berk AJ: Recent lessons in gene expression, cell cycle control, and cell 
biology from adenovirus. Oncogene 2005, 24:7673-7685. 
64. Prasad V, Greber UF: The Endoplasmic Reticulum Unfolded Protein Response 
- Homeostasis and Cell Death in Virus Infections. FEMS Reviews 2021, in 
review. 
65. Prasad V, Suomalainen M, Jasiqi Y, Hemmi S, Hearing P, Hosie L, Burgert HG, 
Greber UF: The UPR sensor IRE1alpha and the adenovirus E3-19K 
glycoprotein sustain persistent and lytic infections. Nat Commun 2020, 
11:1997. 
** This paper describes a feed-forward loop of five components E1A, E3-19K, Ire1a, 
XBP1s and the E1A enhancer / promoter sequence of the viral genome 
harboring XBP1s binding sites, which are necessary to maintain the expression 
of the immediate early adenovirus transactivator E1A in presence of interferon 
for long term viral persistence in human diploid fibroblasts. 
 
 19 
66. Zheng Y, Stamminger T, Hearing P: E2F/Rb Family Proteins Mediate Interferon 
Induced Repression of Adenovirus Immediate Early Transcription to 
Promote Persistent Viral Infection. PLoS Pathog 2016, 12:e1005415. 
67. Fonseca GJ, Thillainadesan G, Yousef AF, Ablack JN, Mossman KL, Torchia J, 
Mymryk JS: Adenovirus evasion of interferon-mediated innate immunity by 
direct antagonism of a cellular histone posttranslational modification. Cell 
Host Microbe 2012, 11:597-606. 
68. Hendrickx R, Stichling N, Koelen J, Kuryk L, Lipiec A, Greber UF: Innate Immunity 
to Adenovirus. Hum Gene Ther 2014, 25:265–284. 
69. Suomalainen M, Prasad V, Kannan A, Greber UF: Cell-to-cell and genome-to-
genome variability of adenovirus transcription tuned by the cell cycle. J 
Cell Sci 2020, 134:jcs.252544. 
* The study visualizes incoming virion DNA by click chemistry combined with single 
RNA fluorescence in situ hybridization detecting E1A mRNA in the nucleus or 
cytoplasm, or intron containing E4 pre-mRNA on transcriptionally active viral 
genomes shortly after nuclear import, thereby revealing extensive cell-to-cell 
and genome-to-genome variability of viral transcription.  
 
70. Wang IH, Suomalainen M, Andriasyan V, Kilcher S, Mercer J, Neef A, Luedtke NW, 
Greber UF: Tracking viral genomes in host cells at single-molecule 
resolution. Cell Host Microbe 2013, 14:468-480. 
71. Xue Y, Johnson JS, Ornelles DA, Lieberman J, Engel DA: Adenovirus protein VII 
functions throughout early phase and interacts with cellular proteins SET 
and pp32. J Virol 2005, 79:2474-2483. 
72. Chen J, Morral N, Engel DA: Transcription releases protein VII from adenovirus 
chromatin. Virology 2007, 369:411-422. 
73. Haruki H, Okuwaki M, Miyagishi M, Taira K, Nagata K: Involvement of template-
activating factor I/SET in transcription of adenovirus early genes as a 
positive-acting factor. J Virol 2006, 80:794-801. 
74. Spector DJ: Default assembly of early adenovirus chromatin. Virology 2007, 
359:116-125. 
75. Georgi F, Andriasyan V, Witte R, Murer L, Hemmi S, Yu L, Grove M, Meili N, Kuttler 
F, Yakimovich A, et al.: The FDA-approved drug Nelfinavir inhibits lytic cell-
free, but not cell-associated non-lytic transmission of human adenovirus. 
Antimicrob Agents Chemother 2020, 64(9):e01002-20. 
* Limiting dilutions of HAdV-C2 yielding single plaque per well reveals both lytic and 
non-lytic AdV spreading modes, the former giving rise to fast growing smeary 
plaques, and the latter slow growing round plaques.  
 
76. Andriasyan V, Yakimovich A, Georgi F, Petkidis A, Witte R, Puntener D, Greber 
UF: Deep learning of virus infections reveals mechanics of lytic cells. 
bioRxiv 2019. 
* Microscopy machine-learning procedures reliably identify HAdV and Herpes simplex 
virus infected cells based on the nuclear chromatin signature in the absence of 
virus stainings, and distinguish between lytic and non-lytic HAdV infected cells. 
 
77. Prasad BV, Schmid MF: Principles of virus structural organization. Adv Exp 
Med Biol 2012, 726:17-47. 
 20 
78. Cello J, Paul AV, Wimmer E: Chemical synthesis of poliovirus cDNA: 
generation of infectious virus in the absence of natural template. Science 
2002, 297:1016-1018. 
79. Malay AD, Miyazaki N, Biela A, Chakraborti S, Majsterkiewicz K, Stupka I, Kaplan 
CS, Kowalczyk A, Piette B, Hochberg GKA, et al.: An ultra-stable gold-
coordinated protein cage displaying reversible assembly. Nature 2019, 
569:438-442. 
* The authors show inducible assembly and disassembly of an artificial protein cage by 
engineering the protein-protein interface of an 11 mer complex with cysteine 
residues, which coordinate gold (I)-triphenylphosphine compounds to form 
stable Archimedean snub cubes, and upon adding reducing agents lead to ready 
disassembly of the cages. 
 
80. Terasaka N, Azuma Y, Hilvert D: Laboratory evolution of virus-like 
nucleocapsids from nonviral protein cages. Proc Natl Acad Sci U S A 2018, 
115:5432-5437. 
81. Sasaki E, Hilvert D: Self-Assembly of Proteinaceous Multishell Structures 
Mediated by a Supercharged Protein. J Phys Chem B 2016, 120:6089-6095. 
82. Tetter S, Terasaka N, Steinauer A, Bingham RJ, Clark S, Scott AP, Patel N, 
Leibundgut M, Wroblewski E, Ban N, et al.: Evolution of a virus-like 
architecture and packaging mechanism in a repurposed bacterial protein. 
bioRxiv 2020. 
** Laboratory evolution experiments highlight practical strategies to evolve designer 
capsids by showing that a bacterial enzyme can be converted to bind its own 
mRNA, and package it against against nucleases with selectivity over other 
RNAs into stable T=4 icosahedral capsids with 240 subunits.  
 
83. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR: Adenovirus protein VI 
mediates membrane disruption following capsid disassembly. J Virol 2005, 
79:1992-2000. 
84. Luisoni S, Suomalainen M, Boucke K, Tanner LB, Wenk MR, Guan XL, Grzybek M, 
Coskun U, Greber UF: Co-option of Membrane Wounding Enables Virus 
Penetration into Cells. Cell Host Microbe 2015, 18:75-85. 
85. Lai CY, Wiethoff CM, Kickhoefer VA, Rome LH, Nemerow GR: Vault nanoparticles 
containing an adenovirus-derived membrane lytic protein facilitate toxin 
and gene transfer. ACS Nano 2009, 3:691-699. 
86. Mahmoudabadi G, Milo R, Phillips R: Energetic cost of building a virus. Proc 
Natl Acad Sci U S A 2017, 114:E4324-E4333. 
87. Ostapchuk P, Hearing P: Regulation of adenovirus packaging. Curr Top 
Microbiol Immunol 2003, 272:165-185. 
88. Eberle P, Holler C, Muller P, Suomalainen M, Greber UF, Eghlidi H, Poulikakos D: 
Single entity resolution valving of nanoscopic species in liquids. Nat 
Nanotechnol 2018. 
* The work describes an on-demand, microfluidic motion control system of single 
immunoglobulin G molecules, quantum dots, lipid vesicles, dielectric and 
metallic particles as well as adenoviruses in electrolytes, revealing a new 




89. de Pablo PJ, Schaap IAT: Atomic Force Microscopy of viruses In Physical 
Virology - Virus Structure and Mechanics. Edited by Greber UF: Springer; 2019. 
Advances in Experimental Medicine and Biology 
90. Brandt L, Cristinelli S, Ciuffi A: Single-Cell Analysis Reveals Heterogeneity of 
Virus Infection, Pathogenicity, and Host Responses: HIV as a Pioneering 






Human cervical epithelial HeLa cells grown on sapphire coverslips were infected with 
HAdV-C5 at a high multiplicity in presence of leptomycin B for 5 h, high pressure frozen 
using liquid nitrogen at 2100 bar, and freeze-substituted. Thin sections of 70 nm 
thickness were imaged using transmission electron microscopy at the Center for 
Microscopy and Image Analysis (ZMB) of the University of Zurich. Virus particle (V), 
microtubule (MT), mitochondrium (Mi). Pixel size 0.8 nm, scale bar 500 nm. 
 
 
